Clinical development of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors: What lessons have we learned?

Manuel Hidalgo

doi:10.1007/978-0-387-73898-7_10

Clinical development of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors: What lessons have we learned?

Manuel Hidalgo

School of Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter

4 Scopus citations

Original language	English (US)
Title of host publication	Targeted Therapies in Cancer
Subtitle of host publication	Myth or Reality
Pages	128-143
Number of pages	16
DOIs	https://doi.org/10.1007/978-0-387-73898-7_10
State	Published - Dec 1 2008

Publication series

Name	Advances in Experimental Medicine and Biology
Volume	610
ISSN (Print)	0065-2598

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)

Access to Document

10.1007/978-0-387-73898-7_10

Cite this

@inbook{b7ac5e0521f14acab8e0a3adf143da9a,

title = "Clinical development of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors: What lessons have we learned?",

author = "Manuel Hidalgo",

year = "2008",

month = dec,

day = "1",

doi = "10.1007/978-0-387-73898-7_10",

language = "English (US)",

isbn = "9780387738970",

series = "Advances in Experimental Medicine and Biology",

pages = "128--143",

booktitle = "Targeted Therapies in Cancer",

}

TY - CHAP

T1 - Clinical development of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

T2 - What lessons have we learned?

AU - Hidalgo, Manuel

PY - 2008/12/1

Y1 - 2008/12/1

UR - http://www.scopus.com/inward/record.url?scp=47949092901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47949092901&partnerID=8YFLogxK

U2 - 10.1007/978-0-387-73898-7_10

DO - 10.1007/978-0-387-73898-7_10

M3 - Chapter

C2 - 18593020

AN - SCOPUS:47949092901

SN - 9780387738970

T3 - Advances in Experimental Medicine and Biology

SP - 128

EP - 143

BT - Targeted Therapies in Cancer

ER -

Clinical development of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors: What lessons have we learned?

Publication series

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this